Synthesis of 3,6,7-substituted-quinoxalin-2-ones for evaluation of antimicrobial and anticancer activity. Part 2

Farmaco

Volumn 54, Issue 3, 1999, Pages 161-168

  Sanna, Paolo ^a   Carta, Antonio ^a   Loriga, Mario ^a   Zanetti, Stefania ^a   Sechi, Leonardo ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

2 Quinoxalinones; Anticancer activities; Antimicrobial activities

Indexed keywords

QUINOXALINE DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN;

ANTI-INFECTIVE AGENTS; DRUG EVALUATION; HUMANS; MOLECULAR STRUCTURE; QUINOXALINES;

EID: 0033620436     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00010-5     Document Type: Article

References (16)

1. Sanna P., Carta A., Loriga M., Zanetti S., Sechi L. Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activity. Farmaco. 53:1998;455-461.
2. P. Sanna, A. Carta, S. Zanetti, Sintesi e valutazione biologica in vitro di carbossi- e carbossietilchinossaline e chinossalinoni variamente sostituiti, Atti II Congr. Congiunto Italiano-Spagnolo di Chimica Farmaceutica, Ferrara, Italy, 30 Aug.-3 Sept. 1995, p. 11.
3. P. Sanna, A. Carta, M. Loriga, S. Zanetti, I. Duprè, Preparazione e valutazione microbiologica in vitro di nuovi derivati 3,4-diidrochinossalinonici variamente sostituiti, Atti XIII Convegno Nazionale della Divisione di Chimica Farmaceutica, Paestum, Italy, 23-27 Sept. 1996, Italian Chemical Society, Rome, p. 176.
4. G.W.H. Cheeseman, R.F. Cookson, Condensed pyrazines, in: Heterocyclic Compounds, vol. 35, Wiley, New York, 1979, pp. 78-94.
5. D.D. Chapman, Tautomerism of 3-alkoxycarbonylmethylene-2-oxo-1,2,3,4-tetrahydro-quinoxaline derivatives, J. Chem. Soc. (C) (1966) 806-807.
6. L'Italien Y.J., Banks C.K. 2-Hydroxy-3-alkylquinoxalines. J. Am. Chem. Soc. 73:1951;3246-3247.
7. Loriga M., Fiore M., Sanna P., Paglietti G. Quinoxaline Chemistry. Part 4. 2-(R)-Anilinoquinoxalines as non classical antifolate agents. Synthesis, structure elucidation and evaluation of in vitro anticancer activity. Farmaco. 50:1995;289-301.
8. Otomasu H., Yoshida K. On the nitration of quinoxalines (addendum). Chem. Pharm. Bull. 8:1960;475-478.
9. Abasolo M.I., Gaozza C.H., Fernandez B.M. Kinetic study on the anelation of heterocycles. 1. Quinoxalinone derivatives synthesized by Hinsberg reaction. J. Heterocyclic Chem. 24:1987;1771-1775.
10. Huisgen R., Herbig K., Siegl A., Huber H. Die addukte primarer und sekundarer Amine an carbonester der Acetylenreihe und ihre Konfiguration. Chem. Ber. 99:1966;2526-2545.
11. National Committee for Clinical Laboratory Standards, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved Standard M7-A2, Villanova, PA, USA, 1990.
12. National Committee for Clinical Laboratory Standards, Methods for determining bactericidal activity of antimicrobial agents, Tentative guidelines, National Committee for Clinical Laboratory Standards, Document M26-T vol. 12, Villanova, PA, USA, 1992, p. 19.
13. Diamond L.S. The establishment of various Trichomonas of animals and men in axenic cultures. J. Parasitol. 43:1957;488-490.
14. Zanetti S., Fiori P.L., Pinna A., Usai S., Carta F., Fadda G. Susceptibility of Acanthamoeba castellanii to contact lens disinfecting solutions. Antimicrob. Agents Chemother. 39:1995;1596-1598.
15. Boyd M.R. Status of the NCI preclinical antitumor drug discovery screen. Princ. Pract. Oncol. 3:1989;1-12.
16. Weislow O.W., Kiser R., Fine D., Bader J., Shoemaker R.H., Boyd M.R. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS antiviral activity. J. Natl. Cancer Inst. 81:1989;577-586.